Triple combination therapy with reverse transcriptase and samples were embedded in paraffin. Sections were stained with protease inhibitors markedly modifies the prognosis of HIV hematoxylin-eosin. Chronic liver disease was classified as infection, with dramatic increase in immune status [1] . The chronic hepatitis or cirrhosis. For an accurate evaluation of the pathophysiology of hepatitis C virus (HCV) infection is still activity of liver disease, a semiquantitative scoring system was debated, especially the respective parts of direct viral cytoused according to the classification of Knodell et al. [5] : peripathic and immune-mediated effects on liver damage [2] . Beneportal necrosis, 0 to 10; intralobular necrosis, 0 to 4; inflammaficial enhancement of immunity could be deleterious in diseases tion, 0 to 4; and fibrosis, 0 to 4. A score for necrotizing and involving immune-mediated mechanisms. Severe liver injuries inflammatory activity was determined by summing the first in HCV-infected patients have been reported after discontinuathree of these four numbers making up the Knodell score. tion of chemotherapy, thus underlining a possible link between
The first liver biopsy showed moderate necrotizing and inenhancement of cellular immunity and worsening of HCVflammatory activity and fibrosis (Knodell score, 8 [1-3-3-1]). A related liver lesions [3] . We have recently shown that anti-HIV second liver biopsy, performed in July 1995 for evaluation of triple therapy does not modify HCV replication [4] . Whether unexplained fever and cholestasis, revealed Mycobacterium anti-HIV triple therapy induces more severe liver lesions in avium-related granulomas (treated by chemotherapy with multi-HCV/HIV-coinfected patients is unknown. We describe a case ple agents including clarithromycin) and mild chronic hepatitis; of rapidly evolving HCV-related cirrhosis that paralleled imthe Knodell score was 2 (0-0-1-1), indicating spontaneous immune restoration and marked decrease in HIV and HCV vireprovement in the hepatic necrotizing and inflammatory activity. was negative for DNA from hepatitis B virus as well as for Her first liver biopsy was performed in September 1993 cytomegalovirus antigen, Epstein-Barr virus, and IgM antibodfor evaluation of HCV-related chronic hepatitis. Liver biopsy ies to herpes simplex virus. Autoantibodies (antinuclear antibodies; antimicrosomal antibodies to liver, kidney, and smooth muscle; and antimitochondrial antibodies) were not detected. Ceruloplasmin, iron, transferrin, and a 1 -antitrypsin levels were patic vascular lesions such as peliosis hepatitis lesions (which Since we suspected that triple therapy played a role in liver deterioration, protease inhibitor therapy was stopped in March have been previously described in HIV-infected patients [5a]); this procedure showed marked activity, and the Knodell score 1997, resulting in improvement in liver function. The patient died 7 months after the first episode of ascites and the death was 15 (4-3-4-4), indicating marked hepatic necrotizing and inflammatory activity and cirrhosis (figure 1). Immunostaining was related to progressive liver failure. for CD8 cells showed an increase in the number of CD8 / T lymphocytes in the liver that paralleled immune restoration Discussion (figure 2). No evidence of biliary disease or drug-induced hepatitis was found; culture of the liver biopsy sample was negative,
We describe an unusual case of rapidly evolving HCVrelated cirrhosis that paralleled restoration of immune status as was specific Ziehl-Neelsen or Grocott-Gomori methenamine -silver nitrate staining. Evolution of biological, immunoin an HIV-infected patient. Spontaneous improvement in the hepatic necrotizing and inflammatory activity was observed logic, and virological markers is summarized in table 1. while the CD4 cell count was decreasing; this occurrence was with hepatic fibrosing cholestasis argues against a direct viral cytopathic effect. Furthermore, severe liver injuries have followed by liver deterioration when immune restoration was achieved with triple therapy with a protease inhibitor and two been reported after discontinuation of chemotherapy for HCV-infected patients [3] , underlining the probable link beother antiretroviral drugs. Such an observation questions the mechanisms of HCV-related chronic hepatitis and the future tween enhancement of cellular immunity and worsening of HCV-related liver lesions. follow-up of HCV/HIV-coinfected patients treated with triple antiretroviral therapy.
Our case suggests but does not definitively conclude that there is a link between protease inhibitor -related immune The pathophysiology of chronic HCV infection is still debated, especially the respective parts of direct viral cytopathic restoration and hepatic deterioration, since a twofold higher incidence of cirrhosis [11] and a rapidly evolving course of and immune-mediated effects on liver damage [2]. More severe liver disease associated with immunosuppression suggests a HCV-related hepatitis [12, 13] have been described for HCV/ HIV-coinfected patients. Nevertheless, our observations sugdirect cytopathic effect of HCV: it may be related to a marked increase in the HCV viral load, which has been associated with gest that dramatic improvement in immune status in HIVinfected patients may have a deleterious impact on the course the so-called fibrosing cholestatic hepatitis syndrome during immunosuppression [6, 7] . On the other hand, immunopathoof HCV coinfection, underlining the need to carefully assess these coinfected patients receiving triple antiretroviral thergenic mechanisms may be involved in HCV infection as suggested by the identification in the liver of CD8 T lymphocytes apy. Such an observation should be confirmed by prospective study. directed against specific HCV antigens in correlation with disease activity [8, 9] .
